MarketInOut Stock Screener Log In | Sign Up
 

Intercure Ltd

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/23/2026
Intercure Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization66.62 mln
Float7.21 mln
Earnings Date10/08/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.62
Likely reliable

Relative Strength

21 / 100
Significantly lagging

Debt / Equity

0.46
Low leverage

Pre-Tax Margin

-17%
Loss-making

ROE

-8.59
Negative

Business Description

InterCure Ltd. is an Israeli company that grows, produces, and sells medical-grade cannabis and cannabis-based products to patients in Israel and abroad, offering both dried cannabis flower and oil-based extracts. The company also holds investments in the biomedical sector and works closely with Cannasoul R&D Ltd. to develop and bring to market cannabis treatments backed by clinical research. Founded in 1994 and based in Herzliya, Israel, InterCure operates across the full supply chain from cultivation to distribution.

Key Fundamentals

EPS-0.94
ROE-8.59
RPS6.50
ROIC-9.95
ROA-4.93
EBITDA, mln-2.60
EV / EBITDA-39.58
EV / EBIT-13.56
Revenue, mln78.54
EV / Revenue1.31

Quote Details

Last 4.53
Change 0.09 (2.03%)
Open 4.50
Volume 1,687
Turnover 7,642.11
Average Volume 4,037.95

Financial Ratios

Pre-Tax Profit Margin-17
Leverage Ratio1.74
Current Ratio1.48
Price / Book0.45
Price / Tangible Book1.02
Price / Cash Flow13.22
Price / Free Cash Flow18.83
Debt / Equity0.46
Price / Sales0.67

Financial Strength

Altman Z-Score0.19
Piotroski F-Score 5 / 9
Beneish M-Score-2.62
Short Ratio0.60
Short % of Float0.04

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.88% 37 / 100   
1 Month -13.88% 24 / 100   
2 Months -0.44% 57 / 100   
6 Months -0.22% 54 / 100   
1 Year -36.64% 23 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog